• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    9/29/25 5:15:35 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email
    8-K
    0001832332false00018323322025-09-292025-09-29

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 29, 2025

     

     

    img25599522_0.jpg

    Aveanna Healthcare Holdings Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-40362

    81-4717209

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    400 Interstate North Parkway SE

     

    Atlanta, Georgia

     

    30339

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 770 441-1580

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, par value $0.01 per share

     

    AVAH

     

    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 7.01 Regulation FD Disclosure.

    On September 29, 2025, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our") made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.

     

    Use of our Website and Social Media to Distribute Material Company Information

     

    We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.

     

    The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit Number

     

     

    Description

    99.1

     

    Aveanna Investor Presentation - September 2025

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

     

     

    AVEANNA HEALTHCARE HOLDINGS INC.

     

     

     

     

    Date:

    September 29, 2025

    By:

    /s/ Matthew Buckhalter

     

     

     

    Matthew Buckhalter
    Chief Financial Officer
    (Principal Financial Officer)

     


    Get the next $AVAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    12/8/2025Outperform
    William Blair
    11/13/2025$11.00Outperform
    BMO Capital Markets
    9/18/2025$10.00Underweight → Neutral
    Analyst
    8/19/2025$9.50Equal Weight → Overweight
    Barclays
    8/19/2025$8.00Sell → Neutral
    UBS
    7/21/2025$6.00Hold → Buy
    Jefferies
    7/2/2025$5.50Equal Weight
    Barclays
    12/13/2023Neutral → Underweight
    JP Morgan
    More analyst ratings

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Aveanna

    William Blair initiated coverage of Aveanna with a rating of Outperform

    12/8/25 8:33:04 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on Aveanna with a new price target

    BMO Capital Markets initiated coverage of Aveanna with a rating of Outperform and set a new price target of $11.00

    11/13/25 9:12:15 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna upgraded by Analyst with a new price target

    Analyst upgraded Aveanna from Underweight to Neutral and set a new price target of $10.00

    9/18/25 8:32:28 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aveanna to Participate at the BofA Securities Home Care Conference

    ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the BofA Securities Home Care Conference virtually on December 9, 2025. Management will present at 12:30pm EST and will also host 1x1 investor meetings that same day. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has l

    12/4/25 5:00:00 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook

    Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted EBITDA for Q3 2025 was $80.1 million, a 67.5% increase over the prior year periodIncreased Full Year 2025 Revenue guidance to greater than $2.375 billion, updated from greater than $2.3 billion Increased Full Year 2025 Adjusted EBITDA guidance to greater than $300 million, updated from greater than $270 million ATLANTA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, hi

    11/6/25 6:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Pricing of Secondary Offering of Common Stock

    ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today the pricing of the previously announced secondary offering by certain selling stockholders affiliated with J.H. Whitney Equity Partners VII, LLC (the "Selling Stockholders") of 10,000,000 shares of its common stock at a public offering price of $9.00 per share (the "Offering"). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of the Company's common stock. The Selling Stockholders will recei

    10/21/25 9:50:51 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner J.H. Whitney Equity Partners Vii, Llc sold $11,267,181 worth of shares (1,251,909 units at $9.00) (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    10/28/25 4:15:06 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner Vigano Paul R sold $13,500,000 worth of shares (1,500,000 units at $9.00) (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    10/28/25 4:15:08 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Large owner Williams Robert M Jr sold $13,500,000 worth of shares (1,500,000 units at $9.00) (SEC Form 4)

    4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

    10/28/25 4:15:04 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    SEC Filings

    View All

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    11/14/25 4:15:29 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Aveanna Healthcare Holdings Inc.

    SCHEDULE 13G/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    11/10/25 4:37:08 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    11/7/25 7:15:28 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Leadership Updates

    Live Leadership Updates

    View All

    Aveanna Healthcare Holdings Announces Appointment of New Director

    ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

    11/4/24 7:30:02 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

    ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

    4/3/24 6:30:06 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

    ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

    12/11/23 7:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/24 4:00:42 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

    SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

    2/14/22 6:43:51 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    $AVAH
    Financials

    Live finance-specific insights

    View All

    Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook

    Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted EBITDA for Q3 2025 was $80.1 million, a 67.5% increase over the prior year periodIncreased Full Year 2025 Revenue guidance to greater than $2.375 billion, updated from greater than $2.3 billion Increased Full Year 2025 Adjusted EBITDA guidance to greater than $300 million, updated from greater than $270 million ATLANTA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, hi

    11/6/25 6:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call

    ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 6, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13755427. The replay will be available until November 13, 2025.

    10/16/25 6:30:42 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

    Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million, a 94.3% increase over the prior year periodAdjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year periodIncreased Full Year 2025 Revenue guidance greater than $2.3 billion, updated from greater than $2.15 billion Increased Full Year 2025 Adjusted EBITDA guidance greater than $270 million, updated from greater than $207 million ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populat

    8/7/25 6:30:05 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care